Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists.
Our CEO Gregg Siegal attended the event and participated in many interesting and educational discussions.
ZoBio attended the 8th RSC-BMCS Fragment-based Drug Discovery meeting which was taking place in Cambridge on the 27-29 March 2022.
The meeting focused on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programs. Great scientific program and fantastic atmosphere delivered a truly memorable conference! We were represented in Cambridge by Marta Carneiro (Head of Structural Biology) and Johan Veerman (Head of Chemistry) who had an opportunity to share their scientific experience and develop plenty of new ideas!
ZoBio participated in Discovery on Target, the industry’s preeminent event on novel drug targets and technologies for drug discovery professionals. The conference highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.